Tumor Immune Contexture Model Predicts Prognosis and Immunotherapy Response in Gastric Cancer
The Journal of Gene Medicine · 2025-12 · 27 (12)
DOI: 10.1002/jgm.70065 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, online erschienen am 17.12.2025. Verfasst von Jiexuan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Immunotherapy, Tumor Microenvironment, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tongji Hospital Talent Program, Shanghai 2023 Annual 'Science and Technology Innovation Action Plan' Special Project for Medical Innovation Research, Shanghai Municipal Health Commission Research Project.
Abstract (Originalsprache)
Background
Gastric cancer (GC) is highly heterogeneous, and current prognostic models fail to fully capture tumor immune characteristics, limiting personalized treatment. This study introduces the Tumor Immune Environment Score (TIES), an immune‐based prognostic model designed to enhance risk stratification and predict response to immunotherapy.
Methods
Transcriptomic and clinical data from seven GC cohorts, comprising a total of 1487 patients, were analyzed. The training cohort included GSE15459, GSE62254, GSE84433, and GSE13861, while the validation cohort comprised GSE26899, GSE26901, and TCGA‐STAD. Immune‐related gene signatures were quantified using ssGSEA and subsequently analyzed via LASSO and Cox regression. Clinical applicability was quantified using decision‐curve analysis (DCA) and reclassification metrics (category‐free NRI/IDI) for TIES versus TIES + pathological stage. Immunotherapy response was assessed using data from GSE183924, and its associations with immune characteristics, molecular alterations, and drug sensitivity were investigated. For experimental confirmation, we established a 12‐gene RT‐qPCR panel in 30 institutional GC specimens and computed a weighted qPCR surrogate (qTIES).
Results
A high TIES was associated with worse OS (HR = 2.44, p < 0.001) and DFS (HR = 2.25, p < 0.001). TIES was an independent prognostic factor and demonstrated superior predictive accuracy compared to TNM staging (AUC = 0.75–0.79 vs. 0.61–0.64, p < 0.001). Integrating clinical‐pathological features with TIES significantly enhanced predictive performance (AUC = 0.75–0.78 vs. 0.61–0.63, p < 0.01). A low TIES was indicative of an immune‐inflamed subtype, characterized by a higher TMB ( p < 0.01) and a greater likelihood of response to immunotherapy (HR = 0.24, p = 0.014). TIES outperformed TIDE in predicting immunotherapy outcomes, achieving a higher OS C‐index (0.780 vs. 0.743) and DFS C‐index (0.664 vs. 0.610). At 3 years, TIES + stage yielded a greater net benefit than TIES alone across clinically relevant thresholds (DCA) and improved NRI/IDI.The qPCR panel reproduced axis biology (CSR/TGF‐βincreased with NK/Th2 decreased), correlated with pathological stage, stratified OS/DFS by Kaplan–Meier, and showed 3‐year discrimination.
Conclusion
TIES represents a robust immune‐based prognostic tool for GC, facilitating improved risk stratification and immunotherapy response prediction. Its integration into clinical practice, particularly in combination with clinical‐pathological features, may enhance personalized treatment strategies and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Förderung
- Tongji Hospital Talent Program
- Shanghai 2023 Annual 'Science and Technology Innovation Action Plan' Special Project for Medical Innovation Research
- Shanghai Municipal Health Commission Research Project
- Tongji Hospital Talent Recruitment
- Shanghai Natural Science Foundation General Program
- Tongji Hospital Clinical Research Project
- Tongji Hospital Talent Recruitment, Key Projects
- Tongji Hospital Talent Program: Ganquan Rising Star
Zitieren
APA
Wang, J., Yang, X., Dai, X., Hu, Z., & Li, X. (2025). Tumor Immune Contexture Model Predicts Prognosis and Immunotherapy Response in Gastric Cancer. The Journal of Gene Medicine, 27(12). https://doi.org/10.1002/jgm.70065
Vancouver
Wang J, Yang X, Dai X, Hu Z, Li X. Tumor Immune Contexture Model Predicts Prognosis and Immunotherapy Response in Gastric Cancer. The Journal of Gene Medicine. 2025;27(12). doi:10.1002/jgm.70065
BibTeX
@article{Wang2025,
author = {Wang, Jiexuan and Yang, Xin and Dai, Xuan and Hu, Zhiqian and Li, Xinxing},
title = {Tumor Immune Contexture Model Predicts Prognosis and Immunotherapy Response in Gastric Cancer},
journal = {The Journal of Gene Medicine},
year = {2025},
volume = {27},
number = {12},
doi = {10.1002/jgm.70065}
}
EUVIMED